2021
Chances and challenges of registry-based pharmacovigilance in multiple sclerosis: lessons learnt from the implementation of the multicenter REGIMS registry.
Simbrich, A. and Thibaut, J. and Khil, L. and Maximov, S. and Wiendl, H. and Berger, K.
Drug Safety 44
(1): 7-15.
January 2021
This list was generated on Wed Apr 21 02:31:25 2021 CEST.
![[feed]](/style/images/feed-icon-14x14.png){kind=icon}
